These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18942708)

  • 1. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
    Riener MO; Wild PJ; Soll C; Knuth A; Jin B; Jungbluth A; Hellerbrand C; Clavien PA; Moch H; Jochum W
    Int J Cancer; 2009 Jan; 124(2):352-7. PubMed ID: 18942708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
    Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
    Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
    Zimmermann AK; Imig J; Klar A; Renner C; Korol D; Fink D; Stadlmann S; Singer G; Knuth A; Moch H; Caduff R
    Virchows Arch; 2013 May; 462(5):565-74. PubMed ID: 23529156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.
    Akcakanat A; Kanda T; Tanabe T; Komukai S; Yajima K; Nakagawa S; Ohashi M; Hatakeyama K
    Int J Cancer; 2006 Jan; 118(1):123-8. PubMed ID: 16003736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
    Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
    Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
    Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
    Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
    Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of MAGE-A peptides and HLA class I molecules in hepatocellular carcinoma.
    Roch N; Kutup A; Vashist Y; Yekebas E; Kalinin V; Izbicki JR
    Anticancer Res; 2010 May; 30(5):1617-23. PubMed ID: 20592351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
    Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas.
    Resnick MB; Sabo E; Kondratev S; Kerner H; Spagnoli GC; Yakirevich E
    Int J Cancer; 2002 Sep; 101(2):190-5. PubMed ID: 12209997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
    Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
    Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
    Sideras K; Bots SJ; Biermann K; Sprengers D; Polak WG; IJzermans JN; de Man RA; Pan Q; Sleijfer S; Bruno MJ; Kwekkeboom J
    Br J Cancer; 2015 Jun; 112(12):1911-20. PubMed ID: 26057582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cancer-testis genes in human hepatocellular carcinomas.
    Luo G; Huang S; Xie X; Stockert E; Chen YT; Kubuschok B; Pfreundschuh M
    Cancer Immun; 2002 Sep; 2():11. PubMed ID: 12747756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].
    Zhang WM; Xiao G; Zhang M; Guo AL; Dong Y; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):202-5. PubMed ID: 16091172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.